The aims of this study were (1) to determine the change in patients' knowledge about their disease and treatment; (2) to assess the percent change in values of glycated hemoglobin (HbA1c) and change in blood pressure in mmHg; and (3) to evaluate adherence status, measured through pill counts. METHODS: A prospective study was conducted using patients with a diagnosis of both T2DM and hypertension at Arauco hospital in Arauco, Chile. Each patient participated in three interviews over a period of six months. The study incorporated a tailored pharmacotherapeutic intervention plan that included written and oral information regarding pathologies and pharmacological treatment. To determine treatment adherence, a pill count method was performed during each interview. Change in patient adherence and knowledge of the diseases and treatments was assessed using the Fisher exact test. The difference in HbA1c and blood pressure between the initial and final sessions was evaluated using Student's t-test. Analyses were performed using SPSS version 17. RESULTS: A total of 50 patients were selected, of whom 33 (66%) were female. At the beginning of the program, 30% of patients were found to be adherent. At the end of the study, this number had increased to 46% (p-value: 0.099). 10% of patients had full knowledge of their disease at baseline. At the end of the study, this number had increased to 66% (p-value < 0.001). After the completion of the interviews, significant decreases were observed for HbA1c (p-value < 0.001), and systolic blood pressure (p-value < 0.001). Stratified by sex, stronger and more significant decreases were observed for females in terms of both HbA1c (0.63%, p-value= 0.003) and systolic blood pressure (17 mmHg, p-value < 0.001). CONCLUSIONS: A pharmacotherapeutic optimization plan based on improved patient adherence and knowledge and implemented for patients with chronic conditions, such as T2DM and hypertension, has had a positive impact on therapeutic outcomes. 
OBJECTIVES:
The aim of the study is to develop and validate a decision aids (DA) fro Arabic depressed patients. METHODS: A six-page DA booklet published by Agency for Health Care Research and Quality (AHRQ) was adapted and translated to Arabic using Brisling's back translation model. The work of Al-Muhtaseb was followed to produce a natural Arabic text. Validation was carried out by 24 experts (Physicians, Pharmacists, Academic staff and depressed Patients).International Patient Decision Aid Standards (IPDAS) Criteria Checklist was used to examine the DA structure and content. RESULTS: Experts strongly agree that the DA will increase patient's recognition, knowledge and understanding of their condition and options, based on (IPDAS). 83% of experts report that DA provide information about options in sufficient detail for decision making, 68% present probabilities of outcomes is an unbiased and understandable way, 85% clarifying and expressing patients values and 87% for structure guidance in deliberation and communication with a total of 81% for the whole content criteria. Secondly, the development process has 63% positive feedback. Particularly, 83% agreed that the information are present in balanced manner, 65% for having a systematic development process, 71% for using a scientific evidence data , 69% for using plain language but less than half of the experts agreed with the disclosing conflicts of interest. Finally, the sum of expected effectiveness criteria got a very high percentage (93%). In addition, experts provided constructive feedback with some modification regarding the language and general layout of the DA. CONCLUSIONS: Up to our knowledge we developed and validated the first Arabic DA based on IPDAS criteria for depressed patients. Future research needed to assess the effectiveness of this DA on depressed patient involvement in SDM. 
PHS79 imPact of StructureD Patient eDucation on quality of life of SoutH inDian DiabeticS

OBJECTIVES:
The normal life of patients is seriously affected by Diabetes Mellitus (DM). According to Diabetes Atlas it is estimated that 61.3 million people live with diabetes in India (2011 estimates) and77.2 million pre-diabetics. The objective of this study was to evaluate the impact of clinical pharmacist intervention by counselling on medication adherence and quality of life of diabetic patients. METHODS: The study sample was extracted from a reputed diabetic clinic of Warangal, India over a period of six months. About 175 patients diagnosed with diabetes were recruited and were randomized into test (n= 85) and control (n= 90). Health Related Quality of Life of patients was assessed using 19 domain Audit of Diabetes Dependent Quality of Life (ADDQoL) questionnaires and medication adherence was assessed using Brief Medication Questionnaire (BMQ). BMQ and ADDQoL questionnaires were administered at baseline and subsequent four follow-ups each of one month duration. Test group patients administered with structured patient education by using various counselling aids on monthly basis and controlled group patients were deprived of the same. The data was subjected to relevant statistics. RESULTS: The study reveals that there is a highest impact of patient education on working life, physical activity, financial condition and their freedom to eat and drink followed by other quality of life domains in diabetic patients. The mean fasting blood sugar and post prandial blood sugar values of each phase were correlated and was
PHS74 imPact of aPPointment-baSeD meDication SyncHronization on exiSting uSerS of cHronic meDicationS
Holdford D. A. , Saxena K. Virginia Commonwealth University, Richmond, VA, USA OBJECTIVES: To compare the medication adherence and persistence of existing users of chronic medications enrolled in a pharmacy chain's appointment-based medication synchronization (ABMS) program, with patients who are not enrolled in the program for the duration of one year. METHODS: A retrospective cohort study compared patients receiving ABMS with matched controls receiving usual standard care. ABMS consisted of an appointment to synchronize the patient's medications to be dispensed on a single appointment day every month, a call to the patient prior to the appointment day to address any prescription changes and to remind the patient, and a patient visit to the pharmacy to pick up the medication. Outcomes measured were 1-year adherence rates using proportion of days covered (PDC) and 1-year non-persistence rates. Data for this study came from prescription claims records of patients taking one of six chronic medication classes during the period of December 1, 2011 to February 28, 2014. ABMS patients were matched with controls on prior adherence behavior, medication class, age, gender, and geographic region. RESULTS: Mean PDC scores ranged from 0.73 to 0.91 for ABMS patients, and from 0.57 to 0.71 for controls depending on the medication class. The percentage of adherent individuals (i.e., PDC≥ 0.8) was 55% to 84% for ABMS participants and 37% to 62% for controls. Odds of adherence was 2.3 to 3.6 times greater with ABMS. Controls became non-persistent (61% to 74%) more often than ABMS patients (33% to 44%) with hazard ratios of nonpersistence being 0.39 to 0.67 for individuals in the program. Compared to controls, study patients had a 33% to 61% lower likelihood of non-persistence, depending on the drug class. CONCLUSIONS: ABMS program in a community pharmacy setting was associated with significant improvements in adherence and persistence for patients who were existing users of chronic medications for at least six months.
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Pinto S. , Hastings T. J. , Bechtol R, Vaidya V. , Khuder S.
University of Toledo, Toledo, OH, USA
OBJECTIVES: To examine the difference in the adherence of patients with metabolic syndrome receiving a hybrid model of care compared to other community pharmacy models. METHODS: Prospective, randomized-control trial design conducted through an integrated delivery network in Northwest Ohio. Patients required to have Paramount health insurance, type 2 diabetes, hypertension, hyperlipidemia, prescribed at least five oral medications, and prescribed an oral medication for each disease state. Patients randomly assigned to one of four groups. The first group received standard pill bottles. The second group received adherence packaging and refill synchronization. The third group received pill bottles and medication therapy management (MTM) using an appointment-based model. The fourth group received the hybrid model, including adherence packaging, refill synchronization, and MTM using the appointment-based model. Adherence was measured using patientreported pill count. RESULTS: The sample (n= 26) was predominantly female, average age 61 years. Types of insurance included Medicaid(7.14%), Medicare(28.57%), and commercial insurance(64.29%). Adherence ranged from 29% to 100% among all participants. Interim, three-month results showed that the greatest improvement in medication adherence over time was seen in the hybrid model group, from 23.6% to 81.6%. CONCLUSIONS: These preliminary results show that the hybrid model group has the potential to positively impact medication adherence. This is an ongoing study. Further results are needed to fully analyze the benefit of the hybrid pharmacy practice model of care. OBJECTIVES: Adherence to antiretroviral therapy (ART) is a main concern in the control of HIV and is associated with treatment success or failure. The aim of this study was to determine adherence to ART using three methods and to identify factors related with non-adherence. METHODS: The study included 225 HIV patients under treatment at Regional Hospital in Concepción, Chile. Adherence was measured through two indirect methods: (1) the simplified medication adherence questionnaire (SMAQ), a survey including four questions with dichotomous answers, one question with a categorical answer, and one question with an open answer; and (2) a pharmacy dispensation register (PDR), which measures adherence through a ratio defined as number of days for which the supply of medication dispensed was prescribed divided by days between prescription fills; and through one direct method: (3) measuring viral load and CD4+ cell count. These methods were compared and a global weighted adherence measure was calculated for the 47 patients that received all three evaluations. RESULTS: According to the SMAQ, 51% of patients were adherent; while 43% were adherent according to PDR, and 50% were adherent according to the direct method. Weighted adherence was 21%. Main causes of non-adherence were: delay in medication refill (43%); lack of information regarding ART (43%); forgetting doses (36%); and adverse reaction (35%). Patients were more adherent to treatment with the combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor (33%) than with the same combination plus protease inhibitor (12%). CONCLUSIONS: Adherence to HIV treatment was below the Chilean average. Because the global weighted average was significantly less than the individual adherence percentages, each method alone is not sufficient to obtain a reliable determination of adherence. An evaluation of the impact of non-adherence behavior on the Chilean national HIV program is recommended.
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